Pelargonium sidoides, also known as umckaloabo, is a member of the geranium family and is native to South Africa. The name "umckaloabo" is derived from two Zulu words: umkhuhlane, meaning "fever- and cough-related diseases," and uhlabo, meaning "chest pain."
For centuries, the roots of Pelargonium sidoides DC. have been used in traditional South African medicine for the treatment of respiratory diseases, diarrhea, dysmenorrhea (painful menstruation), and liver disorders. Extracts of the root have been available without prescription in German pharmacies since 1983 and have been widely used to treat infections of the sinus, throat, and respiratory tract. Recently, an aqueous formulation of the roots of Pelargonium sidoides called EPs 7630® has been studied in humans as a potential treatment for acute bronchitis, acute pharyngitis, and the common cold.
African geranium, catechin, coumarin, coumarin sulfates, coumarin sulphates, ellagitannins, EPs 7630®, gallic acid, gallocatechin, Geranien (German), geranium, geranium root, Kalwerbossie (German), Kapland-Pelargonie (German), Kap-Pelargonie (German), O-galloyl-C-glucosylflavones, Pelargonien (German), Pelargonium, Pelargonium reniforme spp., pelargonium root, Pelargonium sidoides extract, Pelargonium sidoides spp., polyphenols, proanthocyanidins, rabassam, Rabassamin (German), scopoletin, South African geramium, tannins, umckalin.
Note: An ethanolic extract of the roots of Pelargonium sidoides and Pelargonium reniforme has been marketed in Germany under the name "umckaloabo" since 1983.
These uses have been tested in humans or animals. Safety and effectiveness have not always been proven. Some of these conditions are potentially serious, and should be evaluated by a qualified healthcare provider.
Clinical research strongly suggests that umckaloabo may be effective in the treatment of acute bronchitis.
Research has shown that umckaloabo may be effective in the treatment of acute pharyngitis (inflammation of the back of the throat). However, more well-designed trials are needed before a firm conclusion can be made.
Research has shown that umckaloabo may be effective in the treatment of the common cold. However, more well-designed trials are needed before a firm conclusion can be made.